Verismo Therapeutics Announces Upcoming Presentation at SITC 2023
(Adnkronos) – PHILADELPHIA, Nov. 3, 2023 /PRNewswire/ — Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy
